Autoinjectors Market To See Record Break Revenue $5.73 Billion By 2027, At CAGR Of 18.1%
Pune, Maharashtra, India, November 24 2020 (Wiredrelease) Allied Analytics –:According to the report, the global autoinjectors industry was estimated at $1.50 billion in 2019, and is anticipated to hit $5.73 billion by 2027, registering a CAGR of 18.1% from 2020 to 2027.
Drivers, restraints, and opportunities-
Rise in prevalence of anaphylaxis, increase in preference among patients to choose self-administration of injections, and technological advancements in autoinjectors fuel the growth of the global autoinjectors market. On the other hand, availability of alternative treatment options such as general injections and oral tablets impedes the growth to some extent. However, patent expiry of biologics to fuel biosimilar demands is expected to create lucrative opportunities for the key players in the industry.
Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/1461
The disposable autoinjectors segment to dominate by 2027-
Based on type, the disposable autoinjectors segment accounted for more than two-thirds of the global autoinjectors market share in 2019 and is expected to rule the roost by the end of 2027. The same segment is also anticipated to register the fastest CAGR of 18.4% throughout the forecast period. This is because the key market players are highly focused on the development of autoinjector devices.
The home care settings segment to maintain the dominant share-
Based on end user, the home care settings segment contributed to more than three-fifths of the global autoinjectors market revenue in 2019 and is anticipated to lead the trail till 2027. Simultaneously, the same segment would also manifest the fastest CAGR of 18.3% during the study period. This is due to increased patient preference for autoinjectors and rise in prevalence of anaphylaxis.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1461
North America garnered the major share in 2019-
Based on geography, North America generated the highest share in 2019, garnering more than two-fifths of the global autoinjectors market. This is attributed to higher awareness among people, increased adoption of autoinjectors, higher number of the target population, supportive reimbursement policies, and availability of advanced devices in the region. Asia-Pacific, on the other hand, would grow at the fastest CAGR of 18.6% from 2020 to 2027.
The major key players profile Are:
Amgen, Antares Pharma, Becton Dickinson and Company, Eli Lilly and Company, Johnson and Johnson, Mylan N.V., Novartis AG, SHL Medical, Teva Pharmaceutical Industries Ltd and Ypsomed AG.
Other Key players Are:
Biogen Idec, Owen Mumford, Consort Medical, Abbvie, and Gerresheimer.
Access Full Report @ https://www.alliedmarketresearch.com/autoinjector-market
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at firstname.lastname@example.org.